
Maven Income and Growth VCT PLC operates as a venture capital trust. Its investment strategy targets various corporate transactions, including management buy-ins, buy-outs, buy-and-build initiatives, and replacement capital, though it explicitly avoids hostile public-to-private takeovers. The trust maintains a diversified investment portfolio spanning numerous sectors, such as packaging, construction, engineering, transportation, consumer durables and apparel, hospitality, media, retail, healthcare, telecommunications, industrials, non-financials, energy services, financial services, and general consumer goods and services. Its primary focus is on providing capital to smaller, unlisted and AIM-listed companies situated within the United Kingdom. Strict investment limits are observed: no single company receives more than £1 million (or $1.65 million) annually, and no more than 15% of the trust's total assets (at cost) can be allocated to any one business. The trust actively seeks non-executive board representation within its portfolio companies and typically aims for majority shareholdings. For substantial transactions, it retains the flexibility to co-invest with other funds or alongside its own management team.
Maven Income and Growth VCT PLC trades as MIG1.L on LSE. The company is classified in Financial Services / Asset Management - Income and reports in GBP.
The current profile places the business in Asset Management - Income. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.
Latest available fiscal data shows -£3.90M of revenue and £1.09M of net income.
Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.
The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.
Maven Income and Growth VCT PLC can be compared against peers such as Vanguard FTSE Developed Europe ex-U.K. Equity Index Fund GBP Acc, Vanguard FTSE Developed Europe ex-U.K. Equity Index Fund GBP Inc, Vanguard LifeStrategy 40% Equity Fund A Acc, Vanguard LifeStrategy 40% Equity Fund A Inc, Vanguard FTSE Developed Europe ex-U.K. Equity Index Fund Institutional Plus GBP Acc, Vanguard FTSE Developed Europe ex-U.K. Equity Index Fund Institutional Plus GBP Inc.
A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.
Current signals to investigate include market capitalization of £70.05M, beta of -0.08, and return on equity of +1.6%.
This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.
Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.
MIG1.L currently shows total debt of £0 and beta of -0.08. Missing data should be treated as a research gap, not as low risk.
Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.
No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.
Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.
No recent SEC-style filings are available for this symbol yet.
Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.
Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.
Company website: https://www.mavencp.com/investors/venture-capital-trusts/maven-income-and-growth-vct-1
For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.